VIRUSES AND LYMPHOMAS

Contribution of the Epstein–Barr virus to the molecular pathogenesis of Hodgkin lymphoma

G Kapatai and P Murray

The Cancer Research UK Institute for Cancer Studies, Medical School, University of Birmingham, Birmingham, UK

Correspondence to:
Dr P Murray, Department of Pathology, Division of Cancer Studies, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; p.g.murray{at}bham.ac.uk

Although the morphology of the pathognomonic Reed–Sternberg cells of Hodgkin lymphoma (HL) was described over a century ago, it was not until recently that their origin from B lymphocytes was recognised. The demonstration that a proportion of cases of HL harbour the Epstein–Barr virus (EBV) and that its genome is monoclonal in these tumours suggests that the virus contributes to the development of HL in some cases. This review summarises current knowledge of the pathogenesis of HL with particular emphasis on the association with EBV.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Stimson, L., Wood, V., Khan, O., Fotheringham, S., La Thangue, N. B. (2009). HDAC inhibitor-based therapies and haematological malignancy. Ann Oncol 0: mdn792v1-mdn792 [Abstract] [Full Text]  
• Chetaille, B., Bertucci, F., Finetti, P., Esterni, B., Stamatoullas, A., Picquenot, J. M., Copin, M. C., Morschhauser, F., Casasnovas, O., Petrella, T., Molina, T., Vekhoff, A., Feugier, P., Bouabdallah, R., Birnbaum, D., Olive, D., Xerri, L. (2009). Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood 113: 2765-3775 [Abstract] [Full Text]  
• Anderson, L. J., Longnecker, R. (2009). Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo. Blood 113: 108-116 [Abstract] [Full Text]